AstraZeneca Central America and Caribbean
With presence in more than 21 countries, we challenge the limits of science to meet our goal of developing drugs that change the lives of our patients and their families.
The AstraZeneca Central America and Caribbean team is a dedicated and passionate team of the best professionals whose mission is to provide life-changing medicines for patients through science and innovation. Our commitment is to the communities we serve, the health systems and the environment.
Who are we?
We are a global science-led biopharmaceutical company that focuses on the discovery, development and marketing of prescription medicines, for the treatment of diseases mainly in three therapeutic areas: 1. Oncology, 2. Cardiovascular, Renal & Metabolic Diseases and 3. Respiratory & Immunology. Headquartered in Cambridge, UK, we operate in more than 100 countries and our innovative medicines are used by millions of patients worldwide.
Our presence in Central America and the Caribbean - a unique and diverse region - is a cause of pride for all of us who are part of AstraZeneca. We are aware of the challenges our patients and health systems face in the region. So, as we continue to benefit more people with our medicines, we build partnerships to deliver solutions focused on patients and communities´ sustainability that improve the quality of life, while supporting Central American and Caribbean health systems in building capabilities and innovative solutions.
Also located on Costa Rica, is Global Financial Services Americas (GFS Americas) at the heart of the Finance function - accountable to the AstraZeneca (AZ) Group for the design and delivery of high quality, simple to operate transactional finance processes that enable our customers from both Marketing Companies and Manufacturing Sites on the American continent to focus on AZ’s strategic priorities.
At AstraZeneca, each and every one of us firmly believes that science is at the heart of everything we do. Science challenges us to push the boundaries of what is possible. We trust the potential of ideas and pursue them, alone and by collaborating with others, until we have transformed the treatment of the disease.
We are driven by science, building success in our markets and therapeutic areas by continuing to create genuinely innovative drugs and improve access to them. In this way, we are able to offer the greatest benefit to patients, health systems and societies worldwide. Guided by our values and behaviors, our people are empowered and inspired to progress in a setting where they make a difference through science.
We put patients first
We put patients first: “We put patients first” is based on the assimilation that the patient's need is essential to develop and general access to medicines that can change their lives. This requires extensive knowledge of the health sector and the ability to make difficult decisions on behalf of patients.
We follow science
We follow science: “We follow science” is part of everything we do, guides the decisions we make, helps us understand the needs of patients, changes our way of understanding medicines, and is a key part of our conversations with the administration, the prescribers and even patients. We must work to achieve scientific excellence, as well as the highest quality data and analysis that support the decisions we make in the organization.
We do the right thing
We do the right thing: “We do the right thing” refers to a personal commitment to doing what is right, however difficult it may be. This includes striving to be honest and transparent, and committing to honesty. And it is based on the underlying belief that only by doing the right thing can we continue to work in the long term.
We play to win
We play to win: “We play to win” is based on the need for people and teams to set and meet ambitious goals, as well as making difficult decisions and fulfilling them. For them, we must stay aligned during changes and complexities and harness the best talents.
We are entrepreneurs
We are entrepreneurs: “We are entrepreneurs” refers to the need to have active sense of urgency when it comes to taking advantage of opportunities, taking risks, learning from mistakes and persevering to achieve what is not known. Being an entrepreneur does not always mean doing big things; it can also mean taking the initiative and doing small things better.
Ethics & Transparency
Research & Development